Jefferies acknowledged acute liver failure could signal a new safety risk but maintained that the high unmet need for DMD treatments supports the bull case.
Sentiment was buoyed by the CEO's remarks on transitioning key customers to its next-generation lidar technology, securing new contracts and expectations for lidar shipments to at least triple this year.
Piper Sandler, on Thursday, downgraded Rivian to ‘Neutral’ from ‘Overweight’ while reducing its price target to $13 from $19 after struggling to identify upside catalysts for the shares this year.
Oklo has signed an Interface Agreement (IAG) with INL, which will allow the company to begin initial site work on its Aurora nuclear powerhouse in Idaho.
Jeremy Bird, EVP of Driver Experience at Lyft, said that over time, AVs will become more affordable and capable of completing more rides under more conditions than they do today.
The company said its available cash, cash equivalents, and marketable securities will be sufficient to cover the expenses and capital requirements into 2027.
In its most recent 10-K filing, the company disclosed that its contracts with U.S. federal government agencies accounted for approximately 17% of its North American revenues in fiscal 2024.
Paratek will acquire Optniose's outstanding shares for $9 apiece in cash, representing a 50% premium to the stock’s closing trading price of $6 on March 19.
The company said that the project's scope includes 2.2 megawatts of solar arrays and 44 level two electric vehicle charging stations across 11 sites within the district.
The services will include exclusive use of the Facility by ICE, security, maintenance, and food services, as well as access to recreational amenities, medical care, and legal counsel.
According to TheFly, UBS upgraded Southwest to ‘Neutral’ from ‘Sell’ with a price target of $36, while Melius Research upgraded the stock to ‘Hold’ from ‘Sell’ with a price target of $34.
Cruise operators, including Carnival, Royal Caribbean Group (RCL), and Norwegian Cruise Line Holdings (NCLH), reported broadly strong revenue and profit growth last year, driven by robust demand and higher pricing.
CFO James Lucania said on the earnings call that fraud prevention efforts are ongoing, and service expenses are expected to remain elevated through the first half of fiscal 2026.
President Donald Trump's trade tariffs and persisting inflation in the United States have pressured the outlook for businesses, particularly consumer retailers.
Earlier this week, Citi said that it expects the company to post "decent results but guide below consensus, driven by worse consumer mix and NAND underutilization charges.”
As part of the deal, Servier will develop and commercialize the clinical-stage oncology company’s BDTX-4933, a molecule designed to address solid tumors, including non-small cell lung cancer.
The deal aligns with Nvidia’s broader push into synthetic data generation, seen at GTC 2025, which helps developers train AI models with highly customized datasets.
